Prothena Corp Public (PRTA) Total Liabilities (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Total Liabilities of $37.3 million for Q1 2026, down 35.34% year-over-year from $57.7 million in Q1 2025, and down 19.54% quarter-over-quarter from $46.3 million in Q4 2025.
Prothena Corp Public (PRTA) Total Liabilities (2012 - 2026) Analysis & Trends
Prothena Corp Public's Total Liabilities history runs 15 years deep, the most recent figure standing at $37.3 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 35.34% year-over-year to $37.3 million; the TTM figure through Mar 2026 stood at $37.3 million (down 35.34% YoY), while the FY2025 annual figure was $46.3 million, down 23.02% from the prior year.
- Total Liabilities for Q1 2026 stood at $37.3 million, down from $46.3 million in the prior quarter.
- The five-year high for Total Liabilities was $149.8 million in Q3 2022, with the low at $37.3 million in Q1 2026.
- The 5-year median for Total Liabilities is $120.8 million (2024), against an average of $99.3 million.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities sank 55.43% in 2024, then advanced 17.42% in 2025.
- Prothena Corp Public's Total Liabilities stood at $136.0 million in 2022, then slipped by 0.72% to $135.0 million in 2023, then tumbled by 55.43% to $60.2 million in 2024, then retreated by 23.02% to $46.3 million in 2025, then dropped by 19.54% to $37.3 million in 2026.
- Business Quant data shows PRTA's Total Liabilities at $37.3 million in Q1 2026, $46.3 million in Q4 2025, and $57.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | 15.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.69 Mn |
| Mar 31, 2026 | 37.28 Mn |
| Dec 31, 2025 | 46.33 Mn |
| Sep 30, 2025 | 57.64 Mn |
| Jun 30, 2025 | 74.74 Mn |
| Mar 31, 2025 | 57.66 Mn |
| Dec 31, 2024 | 60.18 Mn |
| Sep 30, 2024 | 60.89 Mn |
| Jun 30, 2024 | 63.65 Mn |
| Mar 31, 2024 | 120.80 Mn |
| Dec 31, 2023 | 135.02 Mn |
| Sep 30, 2023 | 129.69 Mn |
| Jun 30, 2023 | 138.97 Mn |
| Mar 31, 2023 | 134.18 Mn |
| Dec 31, 2022 | 135.99 Mn |
| Sep 30, 2022 | 149.79 Mn |
| Jun 30, 2022 | 142.29 Mn |
| Mar 31, 2022 | 142.53 Mn |
| Dec 31, 2021 | 143.32 Mn |
| Sep 30, 2021 | 142.23 Mn |